Case Comprehensive Cancer Center: Carcinoma, Ovarian Epithelial trials
The registry lists 10 Carcinoma, Ovarian Epithelial studies with Case Comprehensive Cancer Center as lead sponsor. 1 are open to participants now and 2 have results posted.
Early Phase 1 1Phase 1 4Phase 2 3Phase 3 1No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian CancerRecruitingNCT06386887Not applicable
- Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological MalignanciesCompletedNCT01079832Phase 2Results posted
- Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for CancerCompletedNCT00245050Phase 3Results posted
- Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACTActive, not recruitingNCT06412510Phase 1/2
- Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerCompletedNCT01652794Phase 1
- Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their CaregiversCompletedNCT00684801
- Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantCompletedNCT00361049Phase 1
- 11C Topotecan PET ImagingTerminatedNCT00253461Early Phase 1
- Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic CancerWithdrawnNCT00118300Phase 1
- Campath-1H + FK506 and Methylprednisolone for GVHDCompletedNCT00109993Phase 2